FATE - Fate Therapeutics Inc
IEX Last Trade
3.68
0.140 3.804%
Share volume: 1,046,976
Last Updated: Fri 30 Aug 2024 09:59:58 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.54
0.14
3.96%
Summary score
10%
Profitability
0%
Dept financing
7%
Liquidity
75%
Performance
4%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-10.27%
Return on assets
-7.48%
Return on sales
-1244.57%
Return on invested capital
-46.8%
Total debt ratio
27.8%
Debt ratio change over timeo
-1.77%
Current Ratio
7.81%
Quick Ratio
7.54%
Cash Position Ratio
3.01%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.63%
Return on assets
-9.65%
Return on sales
-3716.23%
Return on invested capital
-34.44%
Total debt ratio
25.88%
Debt ratio change over timeo
-1.75%
Current Ratio
8.69%
Quick Ratio
8.69%
Cash Position Ratio
4.59%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-11.27%
Return on assets
-8.96%
Return on sales
-2652.88%
Return on invested capital
-36.88%
Total debt ratio
25.23%
Debt ratio change over time
-1.78%
Current Ratio
8.69%
Quick Ratio
8.69%
Cash Position Ratio
8.45%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-74.18%
Return on assets
-80.06%
Return on sales
3360.05%
Return on invested capital
14.09%
Total debt ratio
-177.1%
Debt ratio change over time
-1.77%
Current Ratio
-24.11%
Quick Ratio
-23.55%
Cash Position Ratio
-8.71%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | FATE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -10.27% | 13.79% | 34.47% | 7.43% |
| Return on assets | -7.48% | 2.76% | 3.15% | 5.62% |
| Return on sales | -1244.57% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | -46.8% | 2.36% | 5.39% | 19.77% |
| Profitability | 0% | 43% | 66% | 80% |
| Total debt ratio | 27.8% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -1.77% | 308.97% | -6.99% | 1.18% |
| Dept financing | 8% | 50% | 25% | 7% |
| Current Ratio | 8.69% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.69% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.59% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 8% | 19% | 44% |
| Short-term ratios | FATE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.63% | 13.77% | 13.25% | 3.8% |
| Return on assets | -9.65% | 2.43% | 1.89% | 3.09% |
| Return on sales | -3716.23% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | -34.44% | 2.14% | 3.39% | 9.18% |
| Profitability | 0% | 71% | 68% | 82% |
| Total debt ratio | 25.88% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -1.75% | 46.38% | -72.08% | 1.51% |
| Dept financing | 7% | 50% | 25% | 7% |
| Current Ratio | 8.69% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 8.69% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 4.59% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 18% | 45% |